Limits...
Clinical, Radiographic, and Histologic Evaluation of Maxillary Sinus Lift Procedure Using a Highly Purified Xenogenic Graft (Laddec(®)).

Guarnieri R, Belleggia F, Ippoliti S, DeVilliers P, Stefanelli LV, Di Carlo S, Pompa G - J Oral Maxillofac Res (2016)

Bottom Line: The original height was 3.65 (SD 0.7) mm and the augmented sinus height was 13.8 (SD 1.4) mm after the surgery.The reduced height of grafted xenogenic material (RDL) at the implant insertion was 0.83 (SD 0.38) mm, and at the final postoperative visit was 0.91 (SD 0.25) mm, showing no significant correlation with the follow-up periods by Spearman's test (P = 0.118).In addition, no significant difference in the RDL was observed according to the site of implantation (P = 0.682).

View Article: PubMed Central - HTML - PubMed

Affiliation: Department of Dental and Maxillofacial Sciences, School of Dentistry, University La Sapienza, Roma Italy.

ABSTRACT

Objectives: The aim of this study was to evaluate the clinical, radiographic and histologic results when a highly purified xenogenic bone (Laddec(®)) was used as grafting material in maxillary sinuses.

Material and methods: In fifteen patients requiring unilateral maxillary sinus augmentation, the grafting procedure was performed with Laddec(®). Forty-two implants were installed after a 6 month healing period. The height of the augmented sinus was measured radiographically immediately after augmentation and postoperatively up to 36 months. At the time of implant placement, a bone core was harvested in each patient for histological examination.

Results: The cumulative implant survival rate was 97.6%. The original height was 3.65 (SD 0.7) mm and the augmented sinus height was 13.8 (SD 1.4) mm after the surgery. The reduced height of grafted xenogenic material (RDL) at the implant insertion was 0.83 (SD 0.38) mm, and at the final postoperative visit was 0.91 (SD 0.25) mm, showing no significant correlation with the follow-up periods by Spearman's test (P = 0.118). In addition, no significant difference in the RDL was observed according to the site of implantation (P = 0.682). The mean implant marginal bone loss was 0.38 (SD 0.24) mm. Histological analysis showed the bone cores were composed of 64.72 (SD 3.44)% newly formed bone, 17.41 (SD 2.02)% connective tissue, 16.93 (SD 2.83)% residual graft particles, and 0.94 (SD 0.11)% inflammatory cells.

Conclusions: According to our data, the highly purified xenogenic bone (Laddec(®)), used as graft material in the sinus lift procedure, may create adequate bone volume, and appropriate osseointegration of dental implants.

No MeSH data available.


Related in: MedlinePlus

The Laddec® particles mixed with sterile saline solution and carefully packed in the sinus cavity.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4837607&req=5

fig4: The Laddec® particles mixed with sterile saline solution and carefully packed in the sinus cavity.

Mentions: The Laddec® (BioHorizons, Birmingam, Alabama, USA) particles were mixed with sterile saline solution and carefully packed in the sinus cavity using a plugger (Figure 4). The quantity of Laddec® needed for each augmentation varied from 3 to 5 g. A membrane (Mem-Lok®, BioHorizons, Birmingam, Alabama, USA) was positioned against the packed sinus window and was folded over (Figure 5). The mucoperiosteal flap was then replaced and sutured with multiple horizontal mattress sutures (Figure 6). Sutures were removed 2 weeks after surgery (Figure 7). Postsurgical visits were scheduled at monthly intervals to check the course of healing.


Clinical, Radiographic, and Histologic Evaluation of Maxillary Sinus Lift Procedure Using a Highly Purified Xenogenic Graft (Laddec(®)).

Guarnieri R, Belleggia F, Ippoliti S, DeVilliers P, Stefanelli LV, Di Carlo S, Pompa G - J Oral Maxillofac Res (2016)

The Laddec® particles mixed with sterile saline solution and carefully packed in the sinus cavity.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4837607&req=5

fig4: The Laddec® particles mixed with sterile saline solution and carefully packed in the sinus cavity.
Mentions: The Laddec® (BioHorizons, Birmingam, Alabama, USA) particles were mixed with sterile saline solution and carefully packed in the sinus cavity using a plugger (Figure 4). The quantity of Laddec® needed for each augmentation varied from 3 to 5 g. A membrane (Mem-Lok®, BioHorizons, Birmingam, Alabama, USA) was positioned against the packed sinus window and was folded over (Figure 5). The mucoperiosteal flap was then replaced and sutured with multiple horizontal mattress sutures (Figure 6). Sutures were removed 2 weeks after surgery (Figure 7). Postsurgical visits were scheduled at monthly intervals to check the course of healing.

Bottom Line: The original height was 3.65 (SD 0.7) mm and the augmented sinus height was 13.8 (SD 1.4) mm after the surgery.The reduced height of grafted xenogenic material (RDL) at the implant insertion was 0.83 (SD 0.38) mm, and at the final postoperative visit was 0.91 (SD 0.25) mm, showing no significant correlation with the follow-up periods by Spearman's test (P = 0.118).In addition, no significant difference in the RDL was observed according to the site of implantation (P = 0.682).

View Article: PubMed Central - HTML - PubMed

Affiliation: Department of Dental and Maxillofacial Sciences, School of Dentistry, University La Sapienza, Roma Italy.

ABSTRACT

Objectives: The aim of this study was to evaluate the clinical, radiographic and histologic results when a highly purified xenogenic bone (Laddec(®)) was used as grafting material in maxillary sinuses.

Material and methods: In fifteen patients requiring unilateral maxillary sinus augmentation, the grafting procedure was performed with Laddec(®). Forty-two implants were installed after a 6 month healing period. The height of the augmented sinus was measured radiographically immediately after augmentation and postoperatively up to 36 months. At the time of implant placement, a bone core was harvested in each patient for histological examination.

Results: The cumulative implant survival rate was 97.6%. The original height was 3.65 (SD 0.7) mm and the augmented sinus height was 13.8 (SD 1.4) mm after the surgery. The reduced height of grafted xenogenic material (RDL) at the implant insertion was 0.83 (SD 0.38) mm, and at the final postoperative visit was 0.91 (SD 0.25) mm, showing no significant correlation with the follow-up periods by Spearman's test (P = 0.118). In addition, no significant difference in the RDL was observed according to the site of implantation (P = 0.682). The mean implant marginal bone loss was 0.38 (SD 0.24) mm. Histological analysis showed the bone cores were composed of 64.72 (SD 3.44)% newly formed bone, 17.41 (SD 2.02)% connective tissue, 16.93 (SD 2.83)% residual graft particles, and 0.94 (SD 0.11)% inflammatory cells.

Conclusions: According to our data, the highly purified xenogenic bone (Laddec(®)), used as graft material in the sinus lift procedure, may create adequate bone volume, and appropriate osseointegration of dental implants.

No MeSH data available.


Related in: MedlinePlus